Abstract  Description  Claims  Drawing  Search report  Cited references 

US61169665   [0001] 
US61238052   [0001] 
WO04050851A   [0006]  [0102] 
WO06010915A   [0006]  [0102] 
WO04090102A   [0006]  [0102] 
WO06044459A   [0006]  [0102] 
US5916596A   [0008]  [0130]  [0158]  [0181]  [0185] 
US6506405B   [0008]  [0130]  [0158] 
US6749868B   [0008]  [0130]  [0158]  [0181] 
US6537579B   [0008]  [0130]  [0158] 
US20050004002A   [0008]  [0130]  [0158] 
US20070082838A   [0008]  [0130]  [0158] 
WO0405051A   [0103] 
WO06010915PCT   [0107] 
US5750361A   [0123] 
WO9710887A   [0127] 
WO9900113A   [0130] 
WO08137148A   [0158] 
US6096331A   [0181]  [0185] 
US6537539B   [0181] 

Lancet   [0003] 
Transfusion   [0004] 
Archives of Virology   [0004] 
Nature   [0004] 
Lancet   [0005] 
Lancet   [0005] 
Lancet   [0005] 
Health Protection Agency-Health Protection Report   [0005] 
Proc. Natl. Acad. Sci. USA   [0006] 
Nat Rev Mol. Cell Biol.   [0006] 
Blood infectivity in the transmissible spongiform encephalopathies   [0007] 
J. Virology Method   [0046] 
Congo Red: Prolongs the Incubation Period in Scrapie-infected Hamsters   [0123] 
Effectiveness of Anthracycline Against Experimental Prion Diseases in Syrian Hamsters   [0123] 
Porphyrin and Phthalocyanine Antiscrapie Compounds   [0123] 
Biochemistry   [0123] 
Reversion of Prion Protein Conformational Changes in Synthetic p-sheet Breaker Peptides   [0123] 
Binding of the Protease-sensitive Form of Prion Protein PrP to Sulphated Glycosaminoglycan and Congo Red   [0123] 
Immunodiagnosis of Prion Disease   [0123] 
Binding of Disease-associated Prion Protein to: Plasminogen.   [0123] 
Therapeutic Category and Biological Activity Index   [0181]